Get PT-141 (Bremelanotide) Online in New Hampshire | OmniRx Health
Sexual Wellness Treatment in New Hampshire
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Key Benefits
- Works through the brain to enhance desire and arousal
- Effective for both men and women
- Addresses root causes of low libido rather than just physical response
- FDA-approved active ingredient (Vyleesi for women)
- Unique central mechanism distinct from PDE5 inhibitors
Who is a Good Candidate?
Men and women experiencing low sexual desire (HSDD), reduced libido, or sexual arousal difficulties who want a centrally-acting treatment that addresses desire rather than just the physical mechanics of sexual function.
Starting from $199/month
Serving New Hampshire
New Hampshire embodies independence—and that includes healthcare choices. From the tech corridor of Manchester to the ski towns of the White Mountains, the seacoast communities to the lakes region, OmniRx Health serves the entire Granite State. Our telehealth platform respects your time and privacy, providing expert care without the need to navigate winter roads or wait in crowded waiting rooms. Live free, live healthy, with convenient virtual care.
Our providers are licensed by the New Hampshire Board of Medicine to deliver telehealth throughout the Granite State.
New Hampshire pharmacies in Manchester, Nashua, Concord, and northern communities provide prescription services with statewide delivery.
New Hampshire has telehealth laws that balance provider flexibility with patient protection, supporting virtual care across the state.
New Hampshire insurers cover telehealth services, making virtual care accessible for residents throughout the state.
Frequently Asked Questions
- How does PT-141 work differently from Viagra or Cialis?
- PDE5 inhibitors like sildenafil and tadalafil work by increasing blood flow to the genitals — they improve physical erectile function but do not enhance sexual desire. PT-141 activates melanocortin receptors in the brain that regulate sexual motivation and arousal, addressing the psychological and neurological dimension of sexual response that PDE5 inhibitors do not target.
- Can women use PT-141?
- Yes. PT-141 was originally developed in part to address hypoactive sexual desire disorder (HSDD) in women. Vyleesi (bremelanotide injection) is FDA-approved for premenopausal women with HSDD. It has also demonstrated benefits in men with situational erectile dysfunction related to low desire or performance anxiety.
- How and when is PT-141 administered?
- PT-141 is administered as a subcutaneous injection, typically 45 minutes to 2 hours before anticipated sexual activity to allow sufficient time for central nervous system activation. The injection site is typically the abdomen. Nausea is the most commonly reported side effect and is usually mild and temporary.
- Is telehealth legal in New Hampshire?
- Yes, telehealth is legal in New Hampshire. The state supports virtual healthcare delivery, allowing licensed providers to offer consultations, prescriptions, and ongoing care remotely.
- Can White Mountains residents use telehealth?
- Telehealth is ideal for New Hampshire's mountain communities, where winter weather and distance can make in-person visits challenging. Our platform brings care to you.
- Does New Hampshire insurance cover telehealth?
- Most New Hampshire health insurance plans cover telehealth visits. Coverage varies by plan, but virtual care is widely recognized as a standard care delivery method.